Inhibition of complement activation by intravenous immunoglobulins
✍ Scribed by Ming Qi; JÜRg A. Schifferli
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 121 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The ®rst complement component C1s formed large aggregates with bFGF when bFGF and C1s were incubated at 378C overnight. Under non-reducing conditions, a part of the aggregates did not penetrate into 5% polyacrylamide gel in the presence of SDS, and the rest penetrated into 5% gel but not into 12% ge
High-dose intravenous immunoglobulins (ivlG) were used in a 57-year-old patient with acquired von Willebrand disease in order to correct a hemostatic defect before pneumonectomy for lung carcinoma. IvlG induced a rapid and complete correction of factor Vlll (F VIII) and von Willebrand factor (vWF) a
Since ultraviolet (UV) radiation is a major etiologic factor in the development of human skin cancers, investigating the signal transduction pathways initiated by UV radiation may help with the understanding of the molecular mechanisms of UV-induced carcinogenesis. Our previous studies demonstrated